Use of convalescent plasma therapy in SARS patients in Hong Kong

Article Properties

Language

English
DOI (url)

10.1007/s10096-004-1271-9
Publication Date

2004/12/23
Journal

European Journal of Clinical Microbiology & Infectious Diseases
Indian UGC (Journal)
Refrences

12
Citations

673
Y. Cheng
R. Wong
Y. O. Y. Soo
W. S. Wong
C. K. Lee
M. H. L. Ng
P. Chan
K. C. Wong
C. B. Leung
G. Cheng

Cite

Cheng, Y., et al. “Use of Convalescent Plasma Therapy in SARS Patients in Hong Kong”. European Journal of Clinical Microbiology &Amp; Infectious Diseases, vol. 24, no. 1, 2004, pp. 44-46, https://doi.org/10.1007/s10096-004-1271-9.

Cheng, Y., Wong, R., Soo, Y. O. Y., Wong, W. S., Lee, C. K., Ng, M. H. L., Chan, P., Wong, K. C., Leung, C. B., & Cheng, G. (2004). Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology &Amp; Infectious Diseases, 24(1), 44-46. https://doi.org/10.1007/s10096-004-1271-9

Cheng Y, Wong R, Soo YOY, Wong WS, Lee CK, Ng MHL, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology & Infectious Diseases. 2004;24(1):44-6.

Journal Categories

Medicine

Internal medicine

Infectious and parasitic diseases

Science

Microbiology

Refrences

Refrences Analysis

Category	Category Repetition
Medicine: Medicine (General)	13
Medicine: Internal medicine	4
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy	4
Medicine: Internal medicine: Infectious and parasitic diseases	4
Science: Microbiology	2

The category Medicine: Medicine (General) 13 is the most frequently represented among the references in this article. It primarily includes studies from New England Journal of Medicine The chart below illustrates the number of referenced publications per year.

Refrences used by this article by year

Citations

Citations Analysis

Category	Category Repetition
Medicine: Medicine (General)	204
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy	135
Science: Microbiology	104
Medicine: Internal medicine: Infectious and parasitic diseases	95
Medicine: Therapeutics. Pharmacology	80

The first research to cite this article was titled Neutralizing Antibody Response and SARS Severity and was published in 2005. The most recent citation comes from a 2024 study titled Neutralizing Antibody Response and SARS Severity . This article reached its peak citation in 2020 , with 308 citations.It has been cited in 390 different journals, 30% of which are open access. Among related journals, the Frontiers in Immunology cited this research the most, with 18 citations. The chart below illustrates the annual citation trends for this article.